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Rats fed calcium-deprived diet develop osteoporosis due to enhanced bone resorption, secondary to parathyroid overactivity
resulting from nutritional hypocalcemia. Therefore, rats provide a good experimental animal model for studying bone modelling
alterations during biochemical osteoporosis. Three-month-old Sprague-Dawley male rats were divided into 4 groups: (1) baseline,
(2) normal diet for 4 weeks, (3) calcium-deprived diet for 4 weeks, and (4) calcium-deprived diet for 4 weeks and concomitant
administration of PTH (1-34) 40 𝜇g/Kg/day. Histomorphometrical analyses were made on cortical and trabecular bone of lumbar
vertebral body as well as ofmid-diaphysis and distal metaphysis of femur. In all rats fed calcium-deprived diet, despite the reduction
of trabecular number (due to themaintenance of mineral homeostasis), an intense activity of bone deposition occurs on the surface
of the few remaining trabeculae (in answering to mechanical stresses and, consequently, to maintain the skeletal homeostasis).
Different responses were detected in different sites of cortical bone, depending on their main function in answering mineral or
skeletal homeostasis. This study represents the starting point for work-in-progress researches, with the aim of defining in detail
timing and manners of evolution and recovery of biochemical osteoporosis.
1. Introduction
Osteoporosis is a systemic skeletal disease that represents a
significant public health problem in an increasingly aging
society. It is characterized by net bone loss and microarchi-
tectural deterioration of bone tissue, due to an imbalance
between the resorption and formation phases in the bone
remodelling cycle (increased bone resorption and reduced
bone formation), with a consequent increase in bone fragility
and susceptibility to fracture [1–10]. Osteoporosis can be
mainly due to mechanical disuse or metabolic alterations.
According to the latter, it is well known that both estrogen
and calcium deficiencies are important risk factors in the
pathogenesis of biochemical osteoporosis. Bone development
requires adequate amounts of many nutrients and, among
these, calcium is the most important mineral element, since
the skeleton represents the greatest calcium store in the
body [11]. In fact, more than 95% of the body’s calcium is
present in bone tissue as hydroxyapatite, conferring rigidity,
hardness, and structural integrity to the skeleton [12]. Low
calcium intake (particularly common in many countries)
and important decrease in calcium intestinal absorption are
some of the most important causes involved in bone loss
in aging population. Diet is a modifiable risk factor for
osteoporosis and adequate amounts of calcium are essential
lifelong to maintain healthy bone mass [13, 14]. Several
investigations have underlined the role of serum calcium
variations in etiopathogenesis of osteoporosis and fracture
occurrence; low blood calcium level activates PTH which,
in turn, stimulates the production in the kidney of vitamin
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D that enhances the calcium uptake in the active sites of
duodenum [15], while PTH decreases the urinary excretion
of calcium and stimulates calcium resorption from bone [16].
It is well known that rats fed calcium-deprived diet
develop osteoporosis, as a result of exaggerated bone resorp-
tion, induced by parathyroid overactivity, secondary to nutri-
tional hypocalcemia [17–25]. Therefore, rats provide a good
experimental animal model for studying bone remodelling
alterations during biochemical osteoporosis. It has been
reported by Shen and coworkers [26] that the bone mineral
density in the rat femoral diaphysis was decreased by a
calcium-deficient diet but not by ovariectomy. Other authors
suggested that rat ovariectomy plus calciumdeficiency results
in a great decrease of bone volume and cross-sectional area
compared to the calcium alone [27]. Similar results were
also observed in an investigation of Donahue and coworkers
[28] in which calcium-deficient ovariectomized rats showed
decreased values of bone density, similar to those of estrogen-
deficient osteoporotic women. Hara et al. [29] suggested that
the interaction between ovariectomy and calcium-deficient
diet implies different bone alterations in rats, depending on
different skeletal segments and/or different skeletal regions
with different metabolism. Moreover, dietary calcium defi-
ciency, regardless of ovariectomy, induced bone loss and
increased bone turnover in some skeletal segments, in par-
ticular in the hard palate, mandible, and proximal tibia. It
is interesting to underline that when OVX rats were fed
low calcium diet, the decrease in calcium absorption became
more significant and resulting bone loss was particularly
enhanced [30–32].
The aim of the present investigation was to study how
the mineral and skeletal homeostasis influence the bone loss
in metabolic osteoporosis due to calcium-deprived diet in
different sites of the two bony architectures (trabecular versus
cortical bone) in both axial and appendicular skeleton. This
model seems to be a good starting point for successive studies
on bone alterations during unbalanced calcium metabolism,
frequently occurring in aging, with the final goal of defining
timing and manners of bone mass recovery when calcium is
restored in the diet and verifying the eventual differences of
recovery between compact and spongy bones (i.e., the two
bone architectures with different metabolism and target).
2. Materials and Methods
2.1. Experimental Animals and Treatment. Eighteen 3-
month-old Sprague-Dawley male rats were purchased from
Charles River Laboratories (Calco, Lecco, Italy). All rats
were housed individually in single cages, to better check
food intake of each rat, and maintained under laboratory
controlled conditions (22 ± 1∘C, 55–60% humidity, 12 h
light : 12 h dark). After 7 days of acclimation to housing
conditions, the rats were randomized into four groups,
indicated as follows:
Group 1 (baseline, 𝑛 = 3): sacrificed after 7 days of
acclimation;
Group 2 (control, 𝑛 = 5): fed normal diet for 4 weeks;
Group 3 (𝑛 = 5): fed calcium-deprived diet and
distilled water ad libitum for 4 weeks;
Group 4 (𝑛 = 5): fed calcium-deprived diet and
distilled water ad libitum, plus concomitant admin-
istration of PTH (1-34) 40 𝜇g/kg/day, for 4 weeks.
Both normal and calcium-deprived diets were provided daily;
at different times during the test period, the food container
was briefly removed and weighed to determine quantity of
food consumed.
The calcium-deprived diet is a casein based synthetic diet
containing a very low amount of calcium (0.04% Ca). PTH
(1-34) was supplied by Eli Lilly and Company (Indianapolis,
USA), solubilised in saline (40 𝜇g/mL), and subcutaneously
injected in a volume of 100 𝜇L/100 gr body weight per rat.
Group 1 animals underwent a subcutaneous injection
of calcein (Fluka, St. Louis, MO, USA) 15mg/kg, two days
before the sacrifice. Groups 2, 3, and 4 animals received
a subcutaneous injection of calcein 15mg/kg on the first
day of the experimental period, a subcutaneous injection of
oxytetracycline hydrochloride (Sigma, St. Louis, MO, USA)
30mg/kg after 20 days, and a subcutaneous injection of
Alizarin-Red S (Fluka, St. Louis, MO, USA) 30mg/kg 2 days
before sacrifice, in order to evaluate newly formed bone
during animal treatment.
The body weight of each animal was recorded at the time
of arrival in the housing facility and before euthanasia. At the
end of the treatment, all rats were anesthetized with ether and
blood samples were collected by cardiac puncture; then, rats
were euthanized by exsanguination under ether anesthesia.
All experiments were carried out according to the Bioeth-
ical Committee of the Italian National Institute of Health.
Animal care, maintenance, and surgery were conducted in
accordance with Italian law (D.L. number 116/1992) and
European legislation (EEC number 86/609).
2.2. Histology and Histomorphometry. Soon after euthana-
sia, the fifth lumbar vertebra (L5) and the right femur of
each animal were removed, deprived of soft tissues, fixed
in sodium phosphate-buffered (PBS) 4% paraformaldehyde
pH 7.4, dehydrated in graded ethanol, and embedded in
methyl-methacrylate resin (Sigma Aldrich, Milan, Italy).The
vertebrae and the femurs were transversally cut with a Leica
SP 1600 diamond saw microtome cutting system (Leica
SpA, Milan, Italy) to obtain serial 200 𝜇m thick sections.
The sections, taken from the central level of the lumbar
vertebral body and from the femur mid-diaphysis and distal
metaphysis (for this last considering the more proximal
section of the patellar grove), were glued to a glass slide and
ground to a final thickness of about 40 𝜇m. These sections
were superficially stained with Alizarin-Red and scanned
with Epson 3200 perfection scanner at 3200 dpi resolution to
perform histomorphometry by means of the software Image
J (NIH, Bethesda, USA). The following static histomorpho-
metric parameters were calculated: trabecular bone volume
(BV/TV), trabecular thickness (Tb.Th), trabecular number
(Tb.N), and trabecular separation (Tb.Sp) of the vertebral
bodies and the femoral distal metaphyses; the cortical bone
thickness (Ct.Th) of the anterolateral and posterior sides of
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vertebral bodies; the total cross section area, the cortical bone
area (Ct-B-Ar), and the medullary canal area of the femoral
middiaphyses; the cortical bone area (Ct-B-Ar) of the femoral
metaphyses.
The same sections were also further polished to remove
the Alizarin-Red staining and used for evaluation of dynamic
histomorphometry (by means of bone labelling technique),
as a measure of newly formed bone during animal treatment,
that is, to distinguish preexistent bone with respect to the
bone formed during the period of administration of the
calcium-deprived diet.The sectionswere photographed using
aNikon Eclipse 90imicroscope (Tokyo, Japan) equippedwith
a DS-Fi1 Nikon digital camera and driven by the Nikon ACT-
2U software; dynamic histomorphometric parameters were
evaluated by means of the image analysis system software
Image J (NIH, Bethesda, USA). The newly formed bone
area (Nf B Ar) and the mineral apposition rate (MAR) were
measured between the first two labels (calcein and oxytetra-
cycline) on the anterior and posterior sides of the vertebral
cortical bone as well as on the femoral mid-diaphysis. More-
over, the mineralizing surface (MS), marked with Alizarin,
was measured on the femoral mid-diaphyses as well as on
trabecular bone of vertebral bodies and femur metaphyses.
MAR at the femur metaphyseal level was measured taking
into consideration the second and third label (oxytetracycline
and alizarin). Allmeasurementswere performed according to
the ASBMR histomorphometry nomenclature [33].
In order to evaluate the presence of osteoid seams in
trabecular bone of both femur metaphyses and vertebral
bodies, one section (200 𝜇m thick) adjacent to those used for
histomorphometry was glued to ametacrylate support, cut to
obtain 5 𝜇m thick sections (Reichert-Jung 1150/Autocut), and
stained with Gomori trichrome.The osteoid surface (OS/BS)
was measured on trabecular bone.
2.3. Serum Biochemical Analysis. Blood samples were cen-
trifuged to separate serum that was preserved in tubes,
immediately separated by centrifugation (4∘C) at 1,500 g for
15min. Sera were then aliquoted into small volumes and
stored at −20∘C for successive analyses. The levels of total
calcium (Ca) and inorganic phosphorus (P) in serum were
determined using the high performance Beckman Coulter
analyzer AU680 Chemistry System. The immune-metric
assays for the determination of levels of osteoprotegerin
(OPG), specific bone alkaline phosphatase (BALP), CTX
(Beta CrossLaps), and bioactive-intact-PTH (1-84) in rat
serum were provided by Pantec s.r.l. (Turin, Italy); all kits are
intended for research use only. In particular, rat-OPG and
rat-BALP are two ELISA kits produced by SunRed Hotec-
nology Company (Shanghai, China); RatLaps is an EIA kit
produced by Immunodiagnostic Systems Ltd. (Boldon, UK);
rat bioactive-intact-PTH is an ELISA method produced by
Immunotopics Inc. (San Clemente, CA). The small amounts
of reagents supplied in the kits prevented the possibility
to perform automated procedures on laboratory analytical
platform. To minimize the variables influencing the test, all
good laboratory practice principles were applied: immediate
storage of samples after serum separation at −20∘C; manual
execution of tests in close agreement to the manufacturer’s
Table 1: Body weights of rat at the time of arrival and sacrifice.
Group Arrival weight Sacrifice weight
1 406 ± 48 426 ± 48
2 405 ± 32 526 ± 47
3 405 ± 32 528 ± 70
4 397 ± 25 504 ± 40
All values are expressed as mean ± sd, ANOVA followed by Bonferroni’s
test. Group 1: baseline; Group 2: control, normal diet; Group 3: calcium-
deprived diet for 4 weeks; Group 4: calcium-deprived diet, plus concomitant
administration of PTH (1-34) 40𝜇g/kg/day, for 4 weeks.
instructions; execution of all tests over two consecutive days
in order to avoid repeated freeze/thaw cycles of samples.
2.4. Statistical Analysis. One-way analysis of variance
(ANOVA) with Bonferroni test between treatment groups
and controls was performed using the Software STATA
11.0 (StataCorp, Texas, USA). Values of 𝑃 < 0.05 indicate
significant differences between groups.
3. Results
3.1. BodyWeight. Table 1 reportsmean values of bodyweights
of all groups recorded both at the time of arrival in the
housing facility and at sacrifice; no significant differences
were found among groups.
3.2. Histology and Histomorphometry. The observations
reported in the present paper refer to morphological and
histomorphometric evaluations performed on transverse
sections of the 5th lumbar vertebra and right femur at
middiaphyseal and distal metaphyseal levels of all rats.
3.2.1. Vertebra (L5). Concerning the vertebral sections, in
rats fed calcium-deprived diet, as expected, bone trabeculae
are less abundant and cortical bone appears less thick with
respect to rats fed normal diet (Figure 1).
Table 2 shows themean values of the trabecular bone vol-
ume (BV/TV), the trabecular thickness (Tb.Th), the trabec-
ular number (Tb.N), and the trabecular separation (Tb.Sp).
The results are in line with the morphological observations
in showing a statistically significant decrement of trabecular
bone of the vertebral body in rats fed calcium-deprived diet
(Groups 3 and 4), with respect to rats fed normal diet (Groups
1 and 2). In fact, significant lower values of BV/TV and Tb.N
are observed in both groups of rats fed calcium-deprived
diet with respect to rats fed normal diet. Similar results were
recorded for Tb.Sp, since significant higher distance among
bony trabeculae was recorded in both groups of rats fed
calcium-deprived diet with respect to rats fed normal diet. As
far as trabecular thickness is concerned, instead, significant
lower values of Tb.Thwere recorded only in rats fed calcium-
deprived diet plus PTH (1-34) administration (Group 4) with
respect to baseline rats (Group 1).
The results of cortical bone thickness (Ct.Th) in antero-
lateral as well as in posterior sides of the vertebral body are
shown in Table 3: in the anterolateral side, the mean values
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Table 2: Static histomorphometric parameters of trabecular bone in L5 vertebral body sections.
Group BV/TV (%) Tb.Th (𝜇m) Tb.N (𝑛/mm) Tb.Sp (𝜇m)
1 24.54 ± 2.28 59.56 ± 3.14 4.14 ± 0.54 185.12 ± 28.70
2 23.35 ± 2.31 53.29 ± 2.28 4.39 ± 0.52 180.33 ± 26.25
3 14.97 ± 3.55∗∗,## 50.75 ± 6.50 2.93 ± 0.41∗,## 298.79 ± 53.81∗∗,##
4 14.36 ± 0.73∗∗,## 47.07 ± 2.12∗ 3.03 ± 0.06∗,## 285.34 ± 11.12∗,##
All values are expressed as mean ± sd, ANOVA followed by Bonferroni’s test: ∗𝑃 < 0.05, ∗∗𝑃 < 0.01 versus Group 1; ##𝑃 < 0.001 versus Group 2. Group 1:
baseline; Group 2: control, normal diet; Group 3: calcium-deprived diet for 4 weeks; Group 4: calcium-deprived diet, plus concomitant administration of PTH
(1-34) 40𝜇g/kg/day, for 4 weeks.
Group 1 Group 2
Group 3 Group 4
Figure 1: Scans showing bone histology of the transversal sections of the 5th lumbar vertebral body of all animal groups. Group 1: baseline;
Group 2: control, normal diet; Group 3: calcium-deprived diet for 4 weeks; Group 4: calcium-deprived diet, plus concomitant administration
of PTH (1-34) 40𝜇g/kg/day, for 4 weeks. Scale bar: 500 𝜇m.
are significantly lower in both groups of rats fed a calcium-
deprived diet than in the rats fed a normal diet; otherwise,
in vertebral posterior side the mean values are similar in all
groups.
Figure 2 shows histological transverse sections of the
vertebral body from each animal group, under fluorescence
microscope. The control group as well as the two groups fed
calcium-free diet shows different locations of the labels of
osteogenesis: concerning the anterior cortex the labels are
observed at periosteal level, while in the posterior cortex the
labels are located at the endosteal level. Moreover, in the
two calcium-deprived diet groups, the endosteal surface of
the anterior cortex shows a thinner layer of bone between the
calcein label (injected at the beginning of the experiment) and
the bone marrow surface, with respect to control group.
The results of dynamic histomorphometry show that
both in the anterior and posterior cortical bone the mean
values of Nf B Ar and of MAR are always similar in all
groups (Table 4). The trabecular bone shows intense red
fluorescence (alizarin) mostly located on the surface of the
few trabecular remnants of the groups fed calcium-deprived
diet, being instead scarcely present in the animals fed normal
diet (Figure 2:Groups 3-4 versusGroup 2). Table 4 also shows
the mean values of MS of trabecular bone; the results are
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Group 2 Group 3 Group 4
Figure 2: Fluorescence microscope micrographs showing transverse sections of the 5th lumbar vertebral body. Note the newly formed bone
among three labels in the anterior and posterior cortical bone and the red fluorescencemostly on the surface of the few trabecular remnants of
Groups 3 and 4. Group 2: control, normal diet; Group 3: calcium-deprived diet for 4 weeks; Group 4: calcium-deprived diet, plus concomitant
administration of PTH (1-34) 40 𝜇g/kg/day, for 4 weeks. Scale bar: 500 𝜇m.
Group 1 Group 2 Group 3 Group 4
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Figure 3: Scans showing bone histology of the transversal sections of the femoral mid-diaphysis of all animal groups. Group 1: baseline;
Group 2: control, normal diet; Group 3: calcium-deprived diet for 4 weeks; Group 4: calcium-deprived diet, plus concomitant administration
of PTH (1-34) 40𝜇g/kg/day, for 4 weeks. Scale bar: 750 𝜇m.
in line with the morphological observations in showing a
statistically significant increase of mineralization surface in
the two groups fed calcium-deprived diet with respect to the
control one.
Gomori trichrome stain performed on vertebral trabec-
ular bone does not reveal the presence of osteoid seams
(OS/BS) in all rats of the control group, while the value of
OS/BS in all rat fed calcium-deprived diet ranges from 0 to
24%.
3.2.2. Femoral Mid-Diaphysis. Figure 3 shows the middia-
physeal femoral sections of all animals. In each group, among
all sections observed, two different morphologies were iden-
tified: (i) the more distal mid-diaphyseal sections show oval
appearance; thus they were named “round-shaped” sections;
(ii) the more proximal mid-diaphyseal sections show sharp-
edge appearance (corresponding to the trochanter tertius);
thus they were named “sharp-edge-shaped” sections.
Static histomorphometric parameters are reported in
Table 5. Mean values of total cross section area and cortical
bone area were similar in all groups both in round-shaped and
in sharp-edge-shaped sections. The medullary canal areas are
instead always larger in the rats fed calcium-deprived diets
(Group 3) with respect to baseline and control ones in both
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Figure 4: Fluorescence microscope micrographs showing a portion of transverse sections of the femoral mid-diaphysis. Note in sharp-
edge-shaped sections the new bone deposition mostly located at the periosteal surface (arrows) and bone resorption at the endosteal surface
(arrow heads). Group 2: control, normal diet; Group 3: calcium-deprived diet for 4 weeks; Group 4: calcium-deprived diet, plus concomitant
administration of PTH (1-34) 40 𝜇g/kg/day, for 4 weeks. Scale bar: 500 𝜇m.
Table 3: Static histomorphometric parameters of cortical bone in
L5 vertebral body sections.
Group Anterolateral Ct.Th Posterior Ct.Th
1 311.84 ± 71.47 176.15 ± 33.10
2 321.49 ± 35.97 168.85 ± 26.67
3 197.84 ± 9.54∗∗∗,### 148.23 ± 35.69
4 162.67 ± 10.53∗∗∗,### 130.37 ± 13.37
All values (𝜇m)are expressed asmean± sd,ANOVA followedbyBonferroni’s
test: ∗∗∗𝑃 < 0.001 versus Group 1; ###𝑃 < 0.001 versus Group 2. Group 1:
baseline; Group 2: control, normal diet; Group 3: calcium-deprived diet for 4
weeks; Group 4: calcium-deprived diet, plus concomitant administration of
PTH (1-34) 40𝜇g/kg/day, for 4 weeks.
round-shaped and sharp-edge-shaped sections; this difference
is sometimes significant.
Figure 4 shows, for each animal group, details of histolog-
ical transverse sections of the femur mid-diaphysis observed
under fluorescencemicroscope. Bone labeling (index of bone
osteogenesis) is present mainly at the periosteal surface, in
particular in the sharp-edge-shaped sections in all groups;
moreover, again in particular in sharp-edge-shaped sections,
the endosteal surface shows an irregular outline (index of
bone resorption) in all animals fed a calcium-deprived diet.
The results of dynamic histomorphometry concerning Nf
B Ar, MAR, and MS are shown in Table 6: no significant
differences were observed among all groups in both round-
shaped and sharp-edge-shaped sections at the periosteal and
endosteal level. It must be underlined that in four animals out
of five in the two groups fed a calcium-deprived diet and in
twoout of five animals in the control groupwenever observed
new bone formation at the endosteal level in sharp-edge-
shaped sections; this implies high values of standard deviation
of Nf B Ar and MAR average.
3.2.3. Femoral Metaphysis. Figure 5 shows lower amount of
trabecular bone in all animals fed a calcium-deprived diet
with respect to basal and control ones.
Table 7 concerning static histomorphometry values
shows (a) significant lower values of BV/TV and Tb.N in
Groups 3 and 4 compared to Groups 1 and 2; (b) significantly
increased Tb.Sp values in Groups 3 and 4 compared to
Groups 1 and 2; (c) no differences among all groups for Tb.Th
and Ct-B-Ar.
Figure 6 shows details of histological transverse sections
of the femurmetaphysis, observed under fluorescencemicro-
scope. New bone deposition is observed only at the endosteal
level and around some trabeculae in all animal groups. Data
reported in Table 8 confirm such histological observations; in
particular, the only significant difference is recorded in MS
that is higher in rats fed calcium-deprived diet plus PTH (1-
34) with respect to control ones.
Gomori trichrome stain does not reveal the presence
of osteoid seams (OS/BS) in all rats of the control group,
while the value of OS/BS in all calcium-deprived diet animals
ranges between 0 and 22%.
3.3. Serum Biochemical Analysis. In Table 9 are reported,
for each rat, the values of parameters from sera collected
at the end of experiment. The values of Ca, P, OPG, and
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Table 4: Dynamic histomorphometric parameters in L5 vertebral body sections.
Group Anterior CtNf B Ar (mm2)
Anterior Ct
MAR (𝜇m/day)
Posterior Ct
Nf B Ar (mm2)
Posterior Ct
MAR (𝜇m/day) Tb MS (%)
2 0.063 ± 0.08 4.10 ± 0.71 0.035 ± 0.01 3.47 ± 0.50 11.40 ± 2.30
3 0.075 ± 0.04 4.19 ± 1.40 0.033 ± 0.02 3.26 ± 0.66 53.03 ± 6.44###
4 0.076 ± 0.01 4.22 ± 0.39 0.036 ± 0.07 3.42 ± 0.54 50.80 ± 9.52###
All values are expressed as mean ± sd, ANOVA followed by Bonferroni’s test: ###𝑃 < 0.001 versus Group 2. Group 2: control, normal diet; Group 3: calcium-
deprived diet for 4 weeks; Group 4: calcium-deprived diet, plus concomitant administration of PTH (1-34) 40𝜇g/kg/day, for 4 weeks.
Table 5: Static histomorphometric parameters in middiaphyseal femoral sections.
Group
Round-shaped sections Sharp-edge-shaped sections
Total cross
section area
Cortical bone
area
Medullary canal
area
Total cross
section area
Cortical bone
area
Medullary canal
area
1 11.07 ± 0.61 6.61 ± 0.44 4.36 ± 0.57 10.94 ± 0.50 6.74 ± 0.48 4.19 ± 0.55
2 12.19 ± 1.38 7.35 ± 0.84 4.83 ± 0.54 12.43 ± 1.50 7.73 ± 0.88 4.70 ± 0.53
3 12.71 ± 0.75 6.90 ± 0.48 5.64 ± 0.38∗ 12.97 ± 0.87 7.25 ± 0.68 5.67 ± 0.32∗#
4 11.71 ± 0.78 6.50 ± 0.35 5.17 ± 0.49 12.20 ± 0.89 6.67 ± 0.45 5.50 ± 0.46∗
All values (mm2) are expressed as mean ± sd, ANOVA followed by Bonferroni’s test: ∗𝑃 < 0.05 versus Group 1; #𝑃 < 0.05 versus Group 2. Group 1: baseline;
Group 2: control, normal diet; Group 3: calcium-deprived diet for 4 weeks; Group 4: calcium-deprived diet, plus concomitant administration of PTH (1-34)
40𝜇g/kg/day, for 4 weeks.
Table 6: Dynamic histomorphometric parameters (Nf B Ar-MAR-MS) in middiaphyseal femoral sections.
Group Round-shaped sections Sharp-edge-shaped sections
Periosteal Nf B Ar (mm2) Endosteal Nf B Ar (mm2) Periosteal Nf B Ar (mm2) Endosteal Nf B Ar (mm2)
2 0.27 ± 0.10 0.18 ± 0.15 0.82 ± 0.23 0.05 ± 0.06
3 0.23 ± 0.09 0.14 ± 0.09 0.77 ± 0.34 0.001 ± 0.001
4 0.20 ± 0.10 0.06 ± 0.04 0.80 ± 0.34 0.005 ± 0.012
Periosteal MAR (𝜇m/day) Endosteal MAR (𝜇m/day) Periosteal MAR (𝜇m/day) Endosteal MAR (𝜇m/day)
2 2.38 ± 0.49 1.68 ± 0.92 3.67 ± 0.70 1.09 ± 0.99
3 2.82 ± 1.26 2.25 ± 0.55 3.65 ± 1.13 0.14 ± 0.32
4 2.56 ± 0.59 2.03 ± 1.09 3.84 ± 1.27 0.17 ± 0.37
Periosteal MS (%) Endosteal MS (%) Periosteal MS (%) Endosteal MS (%)
2 52.40 ± 12.91 41.78 ± 18.95 67.39 ± 18.58 29.25 ± 19.06
3 54.89 ± 12.62 42.77 ± 21.83 84.45 ± 10.06 49.94 ± 16.52
4 62.81 ± 14.60 41.81 ± 5.19 72.26 ± 20.26 41.77 ± 7.07
All values are expressed as mean ± sd, ANOVA followed by Bonferroni’s test. Group 1: baseline; Group 2: control, normal diet; Group 3: calcium-deprived diet
for 4 weeks; Group 4: calcium-deprived diet, plus concomitant administration of PTH (1-34) 40𝜇g/kg/day, for 4 weeks.
BALP do not show individual variability among the animals
inside each group; moreover, the mean values do not show
statistically significant differences among the various groups.
Concerning, instead, the values of CrossLaps and PTH (1-
84) the wide individual variability among the animals inside
each group is to be noticed; also for these parameters, no
differences were recorded in the mean values among all
groups.
4. Discussion
The present investigation analyses how the mineral and
skeletal homeostasis influence the bone loss in metabolic
osteoporosis due to calcium-deprived diet in different sites of
the two bony architectures (trabecular versus cortical bone)
in both axial and appendicular skeleton.
The first point to discuss concerns the different amount
of bone mass recorded between the control group and
the two groups of rats fed calcium-deprived diet; in fact,
trabecular bone of vertebral bodies and femoral metaphyses
(Tables 2 and 7) as well as cortical bone of the vertebral
anterolateral part only (Table 3) are significantly reduced in
rats fed calcium-deprived diet. Such bone reduction indicates
that calcium-deprived diet induces marked bone resorption
on those specific bone areas, mainly devoted in answering
metabolic demands, according to the well-known mineral
homeostasis, as also reported by other authors [26, 29, 30,
34, 35]. In all rats fed calcium-deprived diet, despite the
significant reduction of trabecular bone volume and number,
the remaining few trabeculae show active sites of bone
deposition, demonstrated by the intense red fluorescence on
their surfaces as well as by high MS values (Tables 4 and 8);
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Table 7: Static histomorphometric parameters in distal metaphyseal femoral sections.
Group BV/TV (%) Tb.Th (𝜇m) Tb.N (𝑛/mm) Tb.Sp (𝜇m) Ct-B-Ar (mm2)
1 18.26 ± 7.36 51.63 ± 10.19 3.16 ± 0.67 255.36 ± 104.87 6.01 ± 0.41
2 17.76 ± 4.78 50.36 ± 7.92 3.49 ± 0.51 241.08 ± 49.04 5.93 ± 0.70
3 6.94 ± 1.47∗# 42.88 ± 5.01 1.62 ± 0.40∗∗### 601.63 ± 165.23∗∗## 5.71 ± 0.19
4 7.50 ± 2.05∗# 43.89 ± 8.01 1.65 ± 0.19∗∗### 564.60 ± 84.57∗## 5.91 ± 0.60
All values are expressed as mean ± sd, ANOVA followed by Bonferroni’s test: ∗𝑃 < 0.05, ∗∗𝑃 < 0.01 versus Group 1; #𝑃 < 0.05, ##𝑃 < 0.01, and ###𝑃 < 0.001
versus Group 2. Group 1: baseline; Group 2: control, normal diet; Group 3: calcium-deprived diet for 4 weeks; Group 4: calcium-deprived diet, plus concomitant
administration of PTH (1-34) 40𝜇g/kg/day, for 4 weeks.
Group 1 Group 2
Group 3 Group 4
Figure 5: Scans showing bone histology in the transversal sections of the femoral distal metaphysis of all animal groups. Group 1: baseline;
Group 2: control, normal diet; Group 3: calcium-deprived diet for 4 weeks; Group 4: calcium-deprived diet, plus concomitant administration
of PTH (1-34) 40𝜇g/kg/day, for 4 weeks. Scale bar: 1mm.
this evidence does not occur in control group. Similar results
were observed in OS/BS values, showing that new osteoid is
deposited around the few trabecular remnants in calcium-
deprived diet rats only. These findings might explain the fact
that trabecular thickness is similar in all groups. Altogether
these observations agree in suggesting that in all rats fed
calcium-deprived diet bone deposition around the remain-
ing few bony trabeculae occurs in answering mechanical
demands, according to skeletal homeostasis. On the other
hand, in control rats, since no metabolic alterations are
observed and no bone mass loss occurs, skeletal homeostasis
is not altered, the MS value is very low, and the osteoid
secretion (inferable by OS/BS) is absent. Such consideration
is particularly true for vertebral bodies trabeculae, whereas
in femoral metaphyses theMS values showminor differences
between the control group and the groups fed calcium-
deprived diet (the difference reaches statistical significance
only in the group treated with Teriparatide versus control
group). Moreover, at both femoral and vertebral levels, it
is interesting to note that OS/BS values are at least half
the values of MS in calcium-deprived rats; this finding is
probably due to a high osteoid mineralization rate. Our
results are in line with those of Shin and coworkers [36]
that found in rats (4 weeks after ovariectomy) reduction of
BV/TV and Tb N, as well as increase of Tb.Sp of both 4th
lumbar vertebra and femur. They also report that, 8 weeks
after ovariectomy, further increase of Tb.Sp mainly depends
on trabecular thinning at vertebral level and on trabecular
number decrease at femoral level. These last results matched
with the findings of Thompson et al. [37] that observed after
8 weeks from ovariectomy that rat vertebrae lost bone by
thinning trabeculae, whereas proximal tibiae lost bone by
removing trabeculae.
The second point to discuss is that the anterolateral part
of vertebral cortical bone shows intense modelling processes
in all animal groups. In fact, independently of diet type,
new bone deposition always occurs at the periosteal level, as
shown by the presence of the 3 labels of osteogenesis in all
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Group 2 Group 3 Group 4
Figure 6: Fluorescence microscope micrographs showing portions of the transverse sections of the femoral distal metaphysis. New bone
deposition is present only at the endosteal level and around some trabeculae. Group 2: control, normal diet; Group 3: calcium-deprived diet
for 4 weeks; Group 4: calcium-deprived diet, plus concomitant administration of PTH (1-34) 40 𝜇g/kg/day, for 4 weeks. Scale bar: 500 𝜇m.
Table 8: Dynamic histomorphometric parameters in distal meta-
physeal femoral sections.
Group Endosteal MAR (𝜇m/day) Tb MS (%)
2 2.91 ± 0.45 34 ± 7.88
3 2.87 ± 0.11 48 ± 4.55
4 2.81 ± 0.38 50.5 ± 7.23#
All values are expressed as mean ± sd, ANOVA followed by Bonferroni’s test:
#
𝑃 < 0.05 versus Group 2. Group 2: control, normal diet; Group 3: calcium-
deprived diet for 4 weeks; Group 4: calcium-deprived diet, plus concomitant
administration of PTH (1-34) 40𝜇g/kg/day, for 4 weeks.
groups (Figure 2); thus, the lack of calcium in diet does not
alter the amount of newly formed bone (Table 4). In all rats
fed calcium-deprived diet only, intense resorption activity
occurs at the endosteal level that leads to the thinning of
cortical bone, as also shown by the small amount of bone
observed between the calcein label (injected at the beginning
of the experiment) and the bone marrow surface. These
histological and histomorphometrical data suggest that new
bone deposition at the periosteal level likely depends on
mechanical needs, whereas bone resorption at the endosteal
level likely depends on metabolic demands. Moreover, in all
groups the posterior part of vertebral cortical bone shows
modeling processes due to new bone deposition at the
endosteal level, in answering mechanical needs.These results
suggest that cortical bone of the anterolateral side is mainly
involved inmineral homeostasis with respect to the posterior
one; in fact, the thickness of the anterolateral side of the
cortex is significantly lower in rats fed calcium-deprived diet
with respect to the control ones, while the thickness of the
posterior side is similar in all groups.
As regards the femoral mid-diaphysis, the lack of calcium
in the diet leads to an enlargement of the medullary canal
due to resorption at the endosteal level, in particular in
sharp-edge-shaped sections (Figure 3 and Table 5). The find-
ing that only the medullary canal area shows differences
among groups, whereas the cortical bone area does not,
likely depends on the amount of resorbed bone that is
irrelevant when compared to the cortical bone area; this
notwithstanding such difference is significant when com-
pared to the medullary canal area. In sharp-edge-shaped
sections (Figure 4) the medullary canal area increases in all
animals fed calcium-deprived diet due to bone modelling
that implies a marked periosteal bone deposition at the
tertius trochanter (where mechanical loads are greater) and
a significant endosteal bone erosion (where mechanical loads
are lesser). Dynamic histomorphometric results show that (i)
at the periosteal level the amount of newly formed bone is
similar in all groups; (ii) at the endosteal level in sharp-edge-
shaped sections newly formed bone deposition is virtually
absent in animals fed calcium-deprived diet (Table 6) and
the morphology of endosteal surface is irregular since bone
resorption occurs. These observations are in line with data
shown in literature [38] reporting that the pattern of cortical
bone loss in osteoporosis begins from the endosteal surface of
the cortex, where the enlargement of medullary canal occurs
at the expense of the cortex inner side; bone loss usually does
not occur at the periosteal surface.
In femoral cortex metaphysis, the values of Ct-B-Ar
and endosteal MAR do not show differences among groups
(Tables 7 and 8) and probably depend on different factors; Ct-
B-Ar might be due to the high mechanical load acting on the
skeletal region, whereas endostealMAR likely depends on the
bone modeling processes that lead to new bone deposition at
the endosteal level and bone resorption at the periosteal one.
As far as serum parameters are concerned, it is not
surprising to observe after one month of experiment that Ca
and P levels are similar in all groups, as a consequence of
the early bone response by means of mineral homeostasis.
Also serum mean values of OPG and BALP are similar in
all groups, because in all groups bone deposition due to
skeletal growth is not altered by diet, in particular in cortical
bone. Concerning CrossLaps and PTH (1-84), the excessive
individual variability among the animals inside the same
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Table 9: Values of serum levels at the end of the experiments: Ca, P, OPG, BALP, CrossLaps, and PTH (1-84).
Group Ca mg/dL P mg/dL OPG ng/ml BALP ng/ml CrossLaps ng/mL PTH (1-84) pg/ml
1
10.02 7.38 0.75 7.12 38.67 41.24
10.42 5.87 0.67 7.22 59.76 40.65
10.34 7.63 0.72 6.78 73.86 33.59
Mean value ± sd 10.26 ± 0.21 6.96 ± 0.95 0.71 ± 0.04 7.04 ± 0.23 57.40 ± 17.71 38.49 ± 4.25
2
9.89 6.67 0.75 6.53 36.62 45.35
10.14 6.71 0.65 6.94 40.61 80.06
9.46 8.13 0.76 6.51 45.31 84.18
9.48 5.75 0.74 8.00 84.52 31.24
9.75 6.00 0.68 6.55 52.53 31.82
Mean value ± sd 9.74 ± 0.28 6.65 ± 0.92 0.71 ± 0.04 6.90 ± 0.63 51.91 ± 19.16 54.52 ± 25.85
3
9.78 7.00 0.69 6.74 52.77 61.82
10.10 6.55 0.60 6.33 86.80 79.47
10.18 8.78 0.67 7.28 58.20 98.29
9.90 6.86 0.57 6.59 83.06 39.47
10.11 7.57 0.85 7.26 51.01 115.35
Mean value ± sd 10.01 ± 0.16 7.35 ± 0.87 0.67 ± 0.10 6.84 ± 0.41 66.36 ± 17.20 78.88 ± 29.79
4
10.36 6.97 0.70 6.82 120.33 80.06
10.52 5.96 0.67 6.33 38.04 72.41
9.86 7.35 0.76 7.00 85.78 41.24
10.00 7.39 0.62 6.29 62.14 90.65
10.11 7.46 0.71 6.90 47.00 45.35
Mean value ± sd 10.12 ± 0.28 7.04 ± 0.72 0.69 ± 0.05 6.63 ± 0.37 58.24 ± 20.88 62.41 ± 23.35
ANOVA followed by Bonferroni’s test. Group 1: baseline; Group 2: control, normal diet; Group 3: calcium-deprived diet for 4 weeks; Group 4: calcium-deprived
diet, plus concomitant administration of PTH (1-34) 40𝜇g/kg/day, for 4 weeks.
group did not allow understanding and discussing the data
obtained.
In conclusion, the relevance of this paper performed
on the rat model lies in the detailed documentation of
the fact that the lack of calcium in the diet does not lead
to a unique bone answer. It is to be underlined in fact
that the various answers recorded in the different sites of
bony architectures pertaining to specific skeletal segments
are due to the different main involvement of each skeletal
region in maintaining mineral or skeletal homeostasis. As
a consequence, the bone modeling processes are differently
affected in answering induced biochemical osteoporosis.
Regardless of the main topic of the present paper, data here
reported on PTH (1-34) seems to indicate that Teriparatide,
used with good results as therapeutic support in recovering
bone fragility [39–42], does not display preventive effects,
since no significant differences were found between the two
groups of animals fed calcium-deprived diet with/without the
drug administration.
The present investigation based on animal models rep-
resents a good starting point for successive studies on bone
alterations during unbalanced calcium metabolism, as fre-
quently occurring in aging, with the aim of studying in detail
timing and manners of evolution and recovery in human
biochemical osteoporosis with/without administration of
PTH (1-34). In particular, the attention will be focused on the
type of osteogenesis of the newly formed bone during bone
mass recovering that, as previously demonstrated [43, 44],
can occur in two differentmanners (static and dynamic osteo-
genesis) and imply different bone quality by the mechanical
viewpoint.
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